A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

Clinical trial NCT06257758 · TERMINATED

Trial details

NCT number: NCT06257758
Sponsor: Valerio Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Breast Cancer Recurrent Ovarian Cancer Prostate Cancer

Start date: 2024-01-10
Primary completion: 2025-01-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.